美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
16571-698-01	16571-698	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	30 mg/1	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-698-01)
16571-698-03	16571-698	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	30 mg/1	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-698-03)
16571-698-09	16571-698	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	30 mg/1	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-698-09)
16571-698-50	16571-698	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	30 mg/1	500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-698-50)
68071-3585-3	68071-3585	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20240311	N/A	ANDA	ANDA201921	NuCare Pharmaceuticals,Inc.	LANSOPRAZOLE	30 mg/1	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68071-3585-3)
16571-697-50	16571-697	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	15 mg/1	500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-697-50)
16571-697-03	16571-697	HUMAN PRESCRIPTION DRUG	Lansoprazole	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111	N/A	ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	15 mg/1	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16571-697-03)